Author

Yueqi Zhang

Michigan State UniversityORCID 0000-0002-1189-2118Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yueqi Zhang1 paper

Biology Disciplines

Click to filter author papers

Genetics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Andrew DuiD· 1 shared Erica Vandenbulcke· 1 shared Ferzin Sethna· 1 shared Hanbing Cao· 1 shared Hongbing WangiD· 1 shared Hua XiaoiD· 1 shared Hyunu R. Kim· 1 shared Jerry ZhouiD· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Andrew DuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineering

Matthew B. Dong, Kaiyuan Tang, Xiaoyu Zhou, Johanna Shen, Krista Chen, Hyunu R. Kim, Jerry Zhou, Hanbing Cao, Erica Vandenbulcke, Yueqi Zhang, Ryan Dz-Wei Chow, Andrew Du, Kazushi Suzuki, Shao‐Yu Fang, Medha Majety, , Sidi Chen

The paper demonstrates efficient multiplexed gene editing in immune cells using Cas12a/Cpf1 knock-in mice and associated viral vectors.

bioRxiv · Mar 14, 2023 · PreprintGenetics

Computational analysis of transcriptome signature repurposes low dose trifluoperazine for the treatment of fragile X syndrome in mouse model

Qi Ding, Ferzin Sethna, Xueting Wu, Zhuang Miao, Ping Chen, Yueqi Zhang, Hua Xiao, Wei Feng, Yue Feng, Xuan Li, Hongbing Wang

The paper identifies trifluoperazine as a potential treatment for FXS using transcriptome analysis and experimental validation.

Communications Biology · Mar 16, 2020Peer-reviewedNeuroscience